In this talk, Helen Matthews (deputy CEO, Cure Parkinson's Trust) discusses the Linked Clinical Trials Programme and how research into potential new treatments is progressing.

Helen Matthews is Deputy CEO of The Cure Parkinson’s Trust (CPT). She has been involved with CPT since its inception and worked alongside the late charity co-founder Tom Isaacs since 2002. Helen specialises in PR, marketing, event planning and administration. Helen oversees the charity’s current research and patient initiative projects as well as the day to day operations of the charity. Helen sits on CPT’s International Linked Clinical Trials and Research Committees.

If you would like to view the slides from Helen's talk in more detail, please email the team at rapsodi@ucl.ac.uk.

свернуть